Annual Report and Notice of AGM

RNS Number : 3135H

Alliance Pharma PLC

05 April 2022

 

5 April 2022

ALLIANCE PHARMA PLC

("Alliance" or the "Group")

Annual Report & Accounts and Notice of AGM

Alliance Pharma plc (AIM: APH), the international healthcare group, announces that the following documents are now available on the Group's website, www.alliancepharmaceuticals.com :

· The Annual Report & Accounts for the year ended 31 December 2021

· The Notice of the 2022 Annual General Meeting ("AGM"), which will be held at the offices of Alliance at Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB at 10.00am on 18 May 2022.

Printed copies of both documents will be mailed on or before 11 April 2022 to those shareholders who have opted out of receiving electronic communications from the Group.

Printed copies of the documents are also available by contacting Buchanan by email at [e-mail] or by telephoning Buchanan on 020 7466 5000.

For further information:

Alliance Pharma plc	+ 44 (0)1249 705168
Cora McCallum
Head of Investor Relations & Corporate Communications
www.alliancepharma.co.uk
Buchanan	+ 44 (0)20 7466 5000
Mark Court / Sophie Wills / Hannah Ratcliff
Numis Securities Limited	+ 44 (0)20 7260 1000
Nominated Adviser: Freddie Barnfield / Duncan Monteith
Corporate Broking: James Black

Investec Bank plc	+ 44 (0) 20 7597 5970
Corporate Finance: Daniel Adams
Corporate Broking: Patrick Robb

About Alliance

Alliance Pharma plc (AIM: APH) is an international healthcare group. Our purpose is to improve the lives of consumers and patients through making available a range of clinically valuable healthcare products.

Our core focus is on the marketing of Consumer Healthcare brands, complemented by a smaller Prescription Medicines business. In total, we hold marketing rights to around 80 brands, with revenues generated from a mix of direct, distributor and e-commerce sales.

Headquartered in the UK, the Group employs around 250 people based in locations across Europe, North America, and the Asia Pacific region. By outsourcing our manufacturing and logistics operations, we remain asset-light and focused on maximising the value of our brands.

For more information on Alliance, please visit our website : www.alliancepharmaceuticals.com

 

END

 

 

ACSUVRKRURUSRRR